SWX:ASCN

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Ascom Holding AG, together with its subsidiaries, provides healthcare ICT and mobile workflow solutions worldwide. More Details


Snowflake Analysis

Adequate balance sheet with reasonable growth potential.


Similar Companies

Share Price & News

How has Ascom Holding's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ASCN's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

2.0%

ASCN

-0.3%

CH Healthcare Services

1.4%

CH Market


1 Year Return

14.1%

ASCN

22.0%

CH Healthcare Services

4.4%

CH Market

Return vs Industry: ASCN underperformed the Swiss Healthcare Services industry which returned 22% over the past year.

Return vs Market: ASCN exceeded the Swiss Market which returned 4.4% over the past year.


Shareholder returns

ASCNIndustryMarket
7 Day2.0%-0.3%1.4%
30 Day0.8%2.2%3.1%
90 Day72.7%11.3%3.4%
1 Year14.1%14.1%22.9%22.0%8.0%4.4%
3 Year-32.4%-36.0%25.9%21.9%23.0%8.1%
5 Year-21.9%-31.1%74.9%64.2%48.0%23.4%

Price Volatility Vs. Market

How volatile is Ascom Holding's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Ascom Holding undervalued compared to its fair value and its price relative to the market?

10.9%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: ASCN (CHF12.16) is trading below our estimate of fair value (CHF13.64)

Significantly Below Fair Value: ASCN is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: ASCN is unprofitable, so we can't compare its PE Ratio to the XE Healthcare Services industry average.

PE vs Market: ASCN is unprofitable, so we can't compare its PE Ratio to the Swiss market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ASCN's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ASCN is overvalued based on its PB Ratio (7.1x) compared to the XE Healthcare Services industry average (5.1x).


Next Steps

Future Growth

How is Ascom Holding forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

81.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ASCN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (-0.2%).

Earnings vs Market: ASCN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ASCN's is expected to become profitable in the next 3 years.

Revenue vs Market: ASCN's revenue (5.7% per year) is forecast to grow faster than the Swiss market (4.6% per year).

High Growth Revenue: ASCN's revenue (5.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ASCN's Return on Equity is forecast to be low in 3 years time (19.6%).


Next Steps

Past Performance

How has Ascom Holding performed over the past 5 years?

14.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ASCN is currently unprofitable.

Growing Profit Margin: ASCN is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ASCN is unprofitable, but has reduced losses over the past 5 years at a rate of 14% per year.

Accelerating Growth: Unable to compare ASCN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ASCN is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-8.9%).


Return on Equity

High ROE: ASCN has a negative Return on Equity (-10.29%), as it is currently unprofitable.


Next Steps

Financial Health

How is Ascom Holding's financial position?


Financial Position Analysis

Short Term Liabilities: ASCN's short term assets (CHF131.6M) exceed its short term liabilities (CHF115.2M).

Long Term Liabilities: ASCN's short term assets (CHF131.6M) exceed its long term liabilities (CHF24.2M).


Debt to Equity History and Analysis

Debt Level: ASCN's debt to equity ratio (45.8%) is considered high.

Reducing Debt: ASCN's debt to equity ratio has increased from 7.2% to 45.8% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable ASCN has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: ASCN is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 43.5% per year.


Next Steps

Dividend

What is Ascom Holding current dividend yield, its reliability and sustainability?

1.06%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ASCN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ASCN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ASCN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ASCN's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: ASCN is not paying a notable dividend for the Swiss market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ASCN's dividend in 3 years as they are not forecast to pay a notable one for the Swiss market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.9yrs

Average management tenure


CEO

Jeannine Pilloud (56 yo)

1.08yrs

Tenure

CHF939,738

Compensation

Ms. Jeannine Pilloud is serves as Chief Executive officer at Ascom Holding AG since August 2019. Ms. Pilloud served as Chairperson at Ascom Holding AG since April 10, 2019 until November 7, 2019. Ms. Pillo ...


CEO Compensation Analysis

Compensation vs Market: Jeannine's total compensation ($USD1.04M) is about average for companies of similar size in the Swiss market ($USD1.02M).

Compensation vs Earnings: Insufficient data to compare Jeannine's compensation with company performance.


Leadership Team

NamePositionTenureCompensationOwnership
Jeannine Pilloud
Chief Executive Officer1.08yrsCHF939.74k0.044%
CHF 194.2k
Dominik Maurer
CFO & Member of Executive Board0.92yrCHF329.82kno data
Claes Ödman
COO, Head of Global Functions & Member of Executive Board9.25yrsCHF467.72kno data
Francis Schmeer
Chief Sales Officer6yrsCHF500.75k0.0054%
CHF 23.8k
André Neu
CTO & Head of Clinical Solutions Team2.67yrsno datano data
Daniel Lack
Company Secretary and Senior VP of Legalno datano datano data
Gaby Hunziker
Chief Human Resources Officer0.67yrno datano data

1.9yrs

Average Tenure

55yo

Average Age

Experienced Management: ASCN's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Valentin Rueda
Independent Chairman of the Board1.67yrsCHF116.67k0.028%
CHF 121.5k
Nicole Tschudi
Director0.42yrno datano data
Michael Reitermann
Director0.42yrno datano data
Jurg Fedier
Director3.42yrsCHF100.00k0.012%
CHF 53.5k
Andreas Schönenberger
Director0.42yrno datano data
Laurent Dubois
Director0.42yrno datano data

0.4yrs

Average Tenure

58yo

Average Age

Experienced Board: ASCN's board of directors are not considered experienced ( 0.4 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Ascom Holding AG's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Ascom Holding AG
  • Ticker: ASCN
  • Exchange: SWX
  • Founded:
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: CHF437.496m
  • Shares outstanding: 35.98m
  • Website: https://www.ascom.com

Number of Employees


Location

  • Ascom Holding AG
  • Zugerstrasse 32
  • Baar
  • Zug
  • 6340
  • Switzerland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ASCNSWX (SIX Swiss Exchange)YesRegistered SharesCHCHFJan 1992
AH2NDB (Deutsche Boerse AG)YesRegistered SharesDEEURJan 1992
ACML.FOTCPK (Pink Sheets LLC)YesRegistered SharesUSUSDJan 1992
0QONLSE (London Stock Exchange)YesRegistered SharesGBCHFJan 1992

Biography

Ascom Holding AG, together with its subsidiaries, provides healthcare ICT and mobile workflow solutions worldwide. It offers Digistat suite, a patient data management software system; Unite Messaging Suite ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/18 03:34
End of Day Share Price2020/09/17 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.